Alpha 2.0
Login Register
» Authors » Kahren van Eer

Kahren van Eer

Explore the profile of Kahren van Eer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 6
Followers 0
Related Specialties
Microbiology
Oncology
Infectious Diseases
Top 10 Co-Authors
Audrey J King
Renske D M Steenbergen
Tsira Dzebisasjvili
Petra J Woestenberg
Birgit H B van Benthem
Nikki B Thuijs
Ihsane Laabi
Yongsoo Kim
Sylvia Duin
Marit Middeldorp
Published In
J Clin Microbiol
Viruses
Tumour Virus Res
Int J Cancer
J Infect Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
DNA methylation and copy number alterations in the progression of HPV-associated high-grade vulvar intraepithelial lesion
Runello F, Jary A, Duin S, Kim Y, van Eer K, Voss F, et al.
Int J Cancer . 2025 Feb; PMID: 39936378
Human papillomavirus (HPV)-associated high-grade vulvar intraepithelial lesion (HSIL) is a precursor of vulvar squamous cell carcinoma (VSCC). Because of the 8% cancer risk, many vulvar HSIL patients undergo aggressive and...
2.
Comparative Analysis of HPV16 Variants in the Untranslated Regulatory Region, L1, and E6 Genes among Vaccinated and Unvaccinated Young Women: Assessing Vaccine Efficacy and Viral Diversity
van Eer K, Dzebisasjvili T, Steenbergen R, King A
Viruses . 2024 Sep; 16(9). PMID: 39339857
HPV16 is occasionally detected in vaccinated women who received the bivalent HPV16/18 vaccine, usually at low viral loads. This study explored potential differences in HPV16 variants between vaccinated and unvaccinated...
3.
Effects of 2 and 3 Vaccinations With the Bivalent Human Papillomavirus (HPV) Vaccine on the Prevalence and Load of HPV in Clearing and Persistent Infections in Young Women
van Eer K, Middeldorp M, Dzebisasjvili T, Lamkaraf N, de Melker H, Steenbergen R, et al.
J Infect Dis . 2023 Mar; 228(8):1012-1022. PMID: 36988110
Background: Human papillomavirus (HPV) viral load (VL) is associated with persistence, which increases cervical cancer risk. The bivalent vaccine protects against oncogenic HPV-16/18 and cross-protects against several nonvaccine types. We...
4.
The association between viral load and concurrent human papillomavirus infection at the genital and anal sites of young women and the impact of vaccination
van Eer K, Laabi I, van Benthem B, Steenbergen R, King A
Tumour Virus Res . 2021 Dec; 13:200233. PMID: 34958987
Concurrent genital-anal human papillomavirus (HPV) infections may impose an increased anal cancer risk in women with HPV-related genital lesions. High viral load may facilitate genital-anal HPV concurrence. Genital and anal...
5.
Evidence for Missing Positive Results for Human Papilloma Virus 45 (HPV-45) and HPV-59 with the SPF-DEIA-LiPA (Version 1) Platform Compared to Type-Specific Real-Time Quantitative PCR Assays and Impact on Vaccine Effectiveness Estimates
van Eer K, Leussink S, Severs T, van Marm-Wattimena N, Woestenberg P, Bogaards J, et al.
J Clin Microbiol . 2020 Sep; 58(11). PMID: 32907991
Human papillomavirus (HPV) epidemiological and vaccine studies require highly sensitive HPV detection systems. The widely used broad-spectrum SPF-DEIA-LiPA (SPF method) has reduced sensitivity toward HPV-45 and -59. Therefore, anogenital samples...